Biochemistry of Hypertrophy and Heart Failure 2003
DOI: 10.1007/978-1-4419-9238-3_12
|View full text |Cite
|
Sign up to set email alerts
|

Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 17 publications
1
4
0
Order By: Relevance
“…This is consistent with the observation in fusing myoblasts that muscle-derived calpain is exteriorized and acts on extracellular matrix components, such as fibronectin (33). Last, the ultrastructural and immunoblot studies also point to some protection by calpain inhibition of myofibrillar structural proteins, recognized targets of calpains, indicating the action and potential role of this enzyme in muscle disease (41)(42)(43).…”
Section: Discussionsupporting
confidence: 85%
“…This is consistent with the observation in fusing myoblasts that muscle-derived calpain is exteriorized and acts on extracellular matrix components, such as fibronectin (33). Last, the ultrastructural and immunoblot studies also point to some protection by calpain inhibition of myofibrillar structural proteins, recognized targets of calpains, indicating the action and potential role of this enzyme in muscle disease (41)(42)(43).…”
Section: Discussionsupporting
confidence: 85%
“…44 Moreover, phosphorylation of TnI has been shown to protect TnI from degradation. 31,45 Therefore, the decreased TnI phosphorylation observed in remodeled myocardium ( Figure 5G) might render TnI more susceptible to degradation.…”
Section: Reduced Force-generating Capacitymentioning
confidence: 99%
“…In parallel, the loading was visualized by silver staining [23], as described previously [24]. Following the electrophoresis step, myofibrillar proteins were transferred to nitrocellulose membranes, which were subsequently incubated with 5% non-fat dry milk and thereafter with primary antibodies (monoclonal anti-nitrotyrosine (Cayman Chemicals, Ann Arbor, MI, USA), dilution 1 : 5000; polyclonal anti-nitrotyrosine (Upstate, Charlottesville, VA, USA), dilution 1 : 7500; and anti-a-actinin (clone EA-53, Sigma, St. Louis, MO, USA), dilution 1 : 5000).…”
Section: Western Immunoblotmentioning
confidence: 99%